Cormorant Asset Management, LP (CIK 1583977) reported 13 SEC Form 4 insider transactions across 6 companies over the past 18 months (most recent 2026-08-10). Recent activity: Buy BLSM (1.6M shares), Buy BLSM (1.7M shares), Buy BLSM (312,500 shares), Sell DRUG (109,331 shares), Sell CRBP (30,029 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | 10% Owner | Buy | 1.6M | $0 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | 10% Owner | Buy | 1.7M | $0 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. (BLSM) | 10% Owner | Buy | 312,500 | $5.0M |
| 2026-04-30 | BRIGHT MINDS BIOSCIENCES INC. (DRUG) | Insider | Sell | 109,331 | $9.8M |
| 2025-12-15 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Insider | Sell | 30,029 | $344,132 |
| 2025-12-08 | EyePoint, Inc. (EYPT) | Insider | Sell | 60,000 | $942,000 |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 70,748 | $663,616 |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 232,460 | $2.0M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 3.4M | $25.7M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 2.8M | $18.5M |
| 2025-10-01 | MoonLake Immunotherapeutics (MLTX) | Insider | Sell | 5,827 | $40,556 |
| 2025-05-19 | OnKure Therapeutics, Inc. (OKUR) | Insider | Sell | 1.8M | $3.4M |
| 2025-05-14 | OnKure Therapeutics, Inc. (OKUR) | Insider | Sell | 24,300 | $48,357 |
Source: SEC Form 4 filings · as of 2026-08-10